window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Advanced Therapies
  • Biotech & Pharma Business
  • Central Nervous System
  • Clinical & Regulatory
  • Digital & Data
  • Drug Delivery & Formulation
  • Drug Discovery & Development
  • Genomics and sequencing
  • Manufacturing & Supply Chain
  • Medical devices
  • Opinion & Events
  • Pharmaceuticals and therapeutics
  • Research & Development
  • Therapeutic Areas
  • Uncategorised
  • Biotech & Pharma Business,Manufacturing & Supply Chain

    Evonik invests $100M to expand US drug substance manufacturing

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Merck wins FDA Breakthrough Therapy designation for lupus drug enpatoran

    read more
  • Biotech & Pharma Business,Manufacturing & Supply Chain

    SGD Pharma reports emissions reduction and sustainable packaging progress

    read more
  • Advanced Therapies,Digital & Data,Manufacturing & Supply Chain,Research & Development

    Autolomous and Cellular Origins integrate platforms for cell therapy manufacturing

    read more
  • Clinical & Regulatory,Medical devices,Research & Development,Therapeutic Areas

    Alamar launches blood-based eMTBR-Tau assay for Alzheimer’s disease research

    read more
  • Advanced Therapies,Manufacturing & Supply Chain,Medical devices,Research & Development

    Bio-Rad launches Vericheck ddPCR kits for cell and gene therapy quality control

    read more
  • Advanced Therapies,Genomics and sequencing,Research & Development,Therapeutic Areas

    Genespire reports preclinical gene therapy data for methylmalonic acidemia

    read more
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    FORE Biotherapeutics completes enrolment in registrational plixorafenib brain tumour study

    read more
  • Clinical & Regulatory,Digital & Data,Research & Development

    Study quantifies financial benefits of risk-based quality management in oncology trials

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Compass reports second positive Phase 3 trial of psilocybin therapy for treatment-resistant depression

    read more
  • Clinical & Regulatory,Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Healome raises £2M to advance eye-drop technology for ocular surface diseases

    read more
  • Clinical & Regulatory,Medical devices

    Xeltis completes first commercial implant of aXess haemodialysis device

    read more
  • Clinical & Regulatory,Drug Discovery & Development,Research & Development,Therapeutic Areas

    EnteroBiotix doses first patient in Phase 2b IBS-C microbiome trial

    read more
  • Digital & Data,Drug Discovery & Development,Research & Development

    bit.bio launches cell culture media kits for human cell research

    read more
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory

    Cyllene Therapeutics raises €33M to advance EG110A into late-stage development

    read more
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Ananda Pharma begins Phase 2 trial of cannabidiol therapy for chemotherapy nerve damage

    read more
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Erasca reports encouraging Phase 1 data for ERAS-0015 and outlines Phase 3 cancer trials
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Research & Development
  • Tenpoint submits UK application for presbyopia eye drop YUVEZZI
    Categories: Clinical & Regulatory, Medical devices, Pharmaceuticals and therapeutics, Research & Development
  • Q32 Bio reports positive Phase 2 alopecia areata trial results for bempikibart
    Categories: Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top